Zhejiang Jolly Pharmaceutical Co.,LTD (SHE:300181)
China
· Delayed Price · Currency is CNY 16.23
-0.01 (-0.06%)
Mar 10, 2026, 9:25 AM CST
SHE:300181 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 11,251 | 10,545 | 7,477 | 7,484 | 7,097 | 3,591 | Upgrade
|
| Market Cap Growth | 12.10% | 41.03% | -0.09% | 5.46% | 97.63% | 16.83% | Upgrade
|
| Enterprise Value | 11,286 | 10,199 | 6,742 | 7,536 | 7,203 | 3,829 | Upgrade
|
| Last Close Price | 16.23 | 14.80 | 9.98 | 9.77 | 10.41 | 5.20 | Upgrade
|
| PE Ratio | 18.95 | 20.77 | 19.52 | 27.41 | 39.56 | 40.44 | Upgrade
|
| Forward PE | 17.64 | 61.41 | 61.41 | 61.41 | 61.41 | 61.41 | Upgrade
|
| PS Ratio | 4.00 | 4.09 | 3.85 | 4.15 | 4.87 | 3.29 | Upgrade
|
| PB Ratio | 3.54 | 3.74 | 2.70 | 2.71 | 3.58 | 2.09 | Upgrade
|
| P/TBV Ratio | 3.87 | 4.11 | 2.96 | 2.98 | 4.30 | 2.56 | Upgrade
|
| P/FCF Ratio | 397.58 | 308.69 | 47.70 | 53.24 | 68.34 | 16.22 | Upgrade
|
| P/OCF Ratio | 32.24 | 35.50 | 25.92 | 23.49 | 28.18 | 12.84 | Upgrade
|
| EV/Sales Ratio | 4.01 | 3.96 | 3.47 | 4.18 | 4.94 | 3.51 | Upgrade
|
| EV/EBITDA Ratio | 14.14 | 15.51 | 13.95 | 19.92 | 25.92 | 22.35 | Upgrade
|
| EV/EBIT Ratio | 15.61 | 17.27 | 15.99 | 23.43 | 32.12 | 32.60 | Upgrade
|
| EV/FCF Ratio | 398.83 | 298.56 | 43.01 | 53.62 | 69.37 | 17.30 | Upgrade
|
| Debt / Equity Ratio | 0.21 | 0.15 | 0.08 | 0.06 | 0.10 | 0.20 | Upgrade
|
| Debt / EBITDA Ratio | 0.83 | 0.65 | 0.46 | 0.45 | 0.73 | 2.03 | Upgrade
|
| Debt / FCF Ratio | 23.41 | 12.58 | 1.42 | 1.23 | 1.99 | 1.57 | Upgrade
|
| Net Debt / Equity Ratio | -0.01 | -0.13 | -0.31 | -0.33 | -0.05 | 0.02 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.04 | -0.57 | -1.78 | -2.43 | -0.33 | 0.19 | Upgrade
|
| Net Debt / FCF Ratio | -1.06 | -10.98 | -5.49 | -6.54 | -0.88 | 0.15 | Upgrade
|
| Asset Turnover | 0.66 | 0.68 | 0.53 | 0.56 | 0.56 | 0.48 | Upgrade
|
| Inventory Turnover | 2.27 | 2.14 | 1.65 | 1.81 | 1.77 | 1.80 | Upgrade
|
| Quick Ratio | 1.42 | 1.52 | 2.04 | 2.16 | 1.13 | 1.05 | Upgrade
|
| Current Ratio | 1.86 | 2.06 | 2.59 | 2.60 | 1.61 | 1.61 | Upgrade
|
| Return on Equity (ROE) | 20.83% | 18.45% | 14.12% | 12.04% | 10.37% | 6.10% | Upgrade
|
| Return on Assets (ROA) | 10.61% | 9.69% | 7.25% | 6.29% | 5.37% | 3.25% | Upgrade
|
| Return on Invested Capital (ROIC) | 19.95% | 23.44% | 19.66% | 15.19% | 10.63% | 6.07% | Upgrade
|
| Return on Capital Employed (ROCE) | 21.50% | 20.10% | 14.90% | 11.10% | 10.40% | 6.30% | Upgrade
|
| Earnings Yield | 5.30% | 4.82% | 5.12% | 3.65% | 2.53% | 2.47% | Upgrade
|
| FCF Yield | 0.25% | 0.32% | 2.10% | 1.88% | 1.46% | 6.16% | Upgrade
|
| Dividend Yield | 3.69% | 4.05% | 4.51% | 3.07% | 1.92% | 1.92% | Upgrade
|
| Payout Ratio | 72.10% | 63.18% | 55.65% | 53.17% | 39.17% | 34.80% | Upgrade
|
| Buyback Yield / Dilution | -0.12% | 0.10% | -14.76% | 1.93% | -1.64% | -0.12% | Upgrade
|
| Total Shareholder Return | 3.57% | 4.15% | -10.25% | 5.01% | 0.28% | 1.80% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.